429
Views
17
CrossRef citations to date
0
Altmetric
Review

The management of psychosis in movement disorder patients

, &
Pages 935-943 | Published online: 01 May 2007
 

Abstract

Psychosis may be seen with several movement disorders. As pharmacological treatments can sometimes worsen movement disorders, psychosis in these situations can be complex for clinicians to manage. This review covers the management of psychosis in three different movement disorders: Parkinson’s disease, dementia with Lewy bodies and Huntington’s disease.

Disclosure

JH Friedman is a lecture consultant for or has received research funding from: AstraZeneca, Acadia Pharmaceuticals, Ovation Pharmaceuticals Inc, Teva Pharmaceutical Industries Ltd., Guilford Pharmaceuticals Inc., Novartis, Solvay, Sepracor Inc., Cephalon. KL Chou is a lecture consultant for or has received research funding from: Teva Pharmaceutical Industries Ltd., GlaxoSmithKline, Novartis, Boehringer Ingelheim, Solvay.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 99.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 884.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.